197 related articles for article (PubMed ID: 31658461)
1. Diagnostic Approaches to Neuroendocrine Neoplasms of Unknown Primary Site.
Berner AM; Pipinikas C; Ryan A; Dibra H; Moghul I; Webster A; Luong TV; Thirlwell C
Neuroendocrinology; 2020; 110(7-8):563-573. PubMed ID: 31658461
[TBL] [Abstract][Full Text] [Related]
2. Appendiceal neuroendocrine neoplasms: diagnosis and management.
Alexandraki KI; Kaltsas GA; Grozinsky-Glasberg S; Chatzellis E; Grossman AB
Endocr Relat Cancer; 2016 Jan; 23(1):R27-41. PubMed ID: 26483424
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
Catena L; Bichisao E; Milione M; Valente M; Platania M; Pusceddu S; Ducceschi M; Zilembo N; Formisano B; Bajetta E
Tumori; 2011; 97(5):564-7. PubMed ID: 22158484
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
Saller JJ; Haider M; Al-Diffalha S; Coppola D
Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
Uccella S; La Rosa S; Volante M; Papotti M
Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
[TBL] [Abstract][Full Text] [Related]
6. Management of neuroendocrine tumors of unknown primary.
Alexandraki K; Angelousi A; Boutzios G; Kyriakopoulos G; Rontogianni D; Kaltsas G
Rev Endocr Metab Disord; 2017 Dec; 18(4):423-431. PubMed ID: 29199361
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract][Full Text] [Related]
8. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin.
Alexandraki KI; Tsoli M; Kyriakopoulos G; Angelousi A; Nikolopoulos G; Kolomodi D; Kaltsas GA
Minerva Endocrinol; 2019 Dec; 44(4):378-386. PubMed ID: 30991795
[TBL] [Abstract][Full Text] [Related]
10. Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors.
Maxwell JE; O'Dorisio TM; Howe JR
Surg Oncol Clin N Am; 2016 Jan; 25(1):171-94. PubMed ID: 26610781
[TBL] [Abstract][Full Text] [Related]
11. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
Abdel-Rahman O
Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
Kos-Kudła B; Blicharz-Dorniak J; Strzelczyk J; Bałdys-Waligórska A; Bednarczuk T; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Krzakowski M; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nawrocki S; Nowakowska-Duława E; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Zieniewicz K
Endokrynol Pol; 2017; 68(2):79-110. PubMed ID: 28597909
[TBL] [Abstract][Full Text] [Related]
13. Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts.
González I; Lu HC; Sninsky J; Yang C; Bishnupuri K; Dieckgraefe B; Cao D; Chatterjee D
Histopathology; 2019 Oct; 75(4):568-577. PubMed ID: 31077609
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
Yang Z; Klimstra DS; Hruban RH; Tang LH
Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
[TBL] [Abstract][Full Text] [Related]
15. The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors.
Furnari M; Buda A; Delconte G; Citterio D; Voiosu T; Ballardini G; Cavallaro F; Savarino E; Mazzaferro V; Meroni E
J Gastrointestin Liver Dis; 2017 Jun; 26(2):151-156. PubMed ID: 28617885
[TBL] [Abstract][Full Text] [Related]
16. Management of neuroendocrine tumors of unknown origin.
Polish A; Vergo MT; Agulnik M
J Natl Compr Canc Netw; 2011 Dec; 9(12):1397-402; quiz 1403. PubMed ID: 22157557
[TBL] [Abstract][Full Text] [Related]
17. How should incidental NEN of the pancreas and gastrointestinal tract be followed?
Ariotti R; Partelli S; Muffatti F; Andreasi V; Della Sala F; Falconi M
Rev Endocr Metab Disord; 2018 Jun; 19(2):139-144. PubMed ID: 29527619
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic approach to cancer of unknown primary site].
Fernández Cotarelo MJ; Guerra Vales JM
Rev Clin Esp; 2009; 209(7):347-51. PubMed ID: 19709540
[TBL] [Abstract][Full Text] [Related]
19. [Lymph node metastasis removed, occult primary tumor. How to proceed?].
Füessl HS; Stiefelhagen P
MMW Fortschr Med; 2012 Nov; 154(20):32. PubMed ID: 23234116
[No Abstract] [Full Text] [Related]
20. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
Fottner C; Ferrata M; Weber MM
Rev Endocr Metab Disord; 2017 Dec; 18(4):393-410. PubMed ID: 29256148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]